军事知识服务平台
富马酸卢帕他定调控变应性鼻炎炎性反应的分子机制研究进展
Research progress on the molecular mechanisms of rupatadine fumarate in regulating inflammatory responses in al-lergic rhinitis
摘要 变应性鼻炎(AR)是由免疫球蛋白 E 介导、多种炎性反应细胞与介质共同参与的鼻黏膜慢性非感染性炎性反应疾病,病理过程包括速发相与迟发相反应,与肥大细胞脱颗粒、嗜酸性粒细胞浸润、促炎因子释放及多条信号通路异常激活有关.富马酸卢帕他定作为第二代非镇静抗组胺药物,兼具选择性组胺 H1 受体反向激动与血小板活化因子受体非竞争性拮抗作用,从受体阻断、细胞调控、信号通路抑制等方面干预 AR 炎性反应网络.本文系统梳理富马酸卢帕他定对 AR 核心炎性反应介质、关键效应细胞、经典炎性反应信号通路的调控机制,总结其药理特性、抗炎优势及体内外研究证据,对比分析其与传统抗组胺药的分子作用差异,为 AR 基础研究、临床精准用药及新型抗过敏药物研发提供系统的理论参考.
Abstract:
Allergic rhinitis(AR)is a chronic non-infectious inflammatory disease of the nasal mucosa mediated by immunoglobulin E(IgE)and involving multiple inflammatory cells and mediators.Its pathological process includes early-phase and late-phase reactions,which are associated with mast cell degranulation,eosinophil infiltration,release of pro-inflam-matory cytokines,and aberrant activation of multiple signaling pathways.Rupatadine fumarate,a second-generation non-seda-ting antihistamine,possesses selective histamine H1 receptor inverse agonism and non-competitive antagonism of platelet-acti-vating factor(PAF)receptors.These dual properties enable it to intervene in the AR inflammatory network through receptor blockade,cellular modulation,and inhibition of key signaling pathways.This article systematically reviews the regulatory mechanisms of rupatadine fumarate on core inflammatory mediators,key effector cells,and classical signaling pathways in AR.It summarizes the pharmacological characteristics,anti-inflammatory advantages,and in vitro and in vivo research evidence,and provides an in-depth analysis of its molecular action features in comparison with traditional antihistamines.This review aims to provide a systematic theoretical reference for basic research,clinical precision medication,and the development of no-vel anti-allergic drugs for AR.
刊 名 疑难病杂志 ISTIC
年,卷(期): 2026, 25(10)
分类号: R765.21
机标分类号: R75 R562.25 R285.5
在线出版日期: 2026年10月29日